Nanox sees stock slide after FDA finds deficiencies in application for novel imaging system

Radiology startup Nanox saw its stock slide on Thursday after revealing that the U.S. Food and Drug Administration has found deficiencies in its application to rollout a novel imaging system.

The Israel-based firm first submitted a 510(k) premarket application for the commercial version of its multi-source, digital tomosynthesis Nanox.ARC back in June. But FDA reviewers have now placed the application on hold until Nanox addresses a list of deficiencies, according to a filing with the Securities and Exchange Commission.

Nanox said it plans to respond by the due date: 180 days after the feds’ request for additional information.

“The company expects to continue to optimize and develop further features of Nanox.ARC and is considering submitting an additional 510(k) application for the next version of multi-source Nanox.ARC during the fourth quarter of 2021, which will benefit from the FDA’s feedback on the first version of the multi-source Nanox.ARC,” officials said in the Aug. 19 SEC filing.

Nanox previously scored FDA clearance for the single-source version of its X-ray technology in April and has indicated it hopes to deploy the first 15,000 scanners by 2025. Meanwhile, the startup just recently announced plans to acquire artificial intelligence firm Zebra Medical and teleradiology group USARad for $230 million, while also appointing a new CEO.

Innovation at work

Momentum. You feel it when you’ve got it. And when it lags, you’re pushing harder to regain your stride. In radiology, maintaining momentum is core to keeping radiologists, workflow, decision-making and patient care moving forward. An enterprise imaging solution is the orchestrator that’s making it happen.

Sponsored by Sectra

Around the web

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

Signify Research outlines several key technologies and trends in MRI to look for at the Radiological Society of North America 2022 meeting.

Leading up to the 2022 RSNA meeting, Signify Research shares the trends and new innovations in CT scanner technology it has seen in recent years.

Trimed Popup
Trimed Popup